These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26994591)

  • 1. Bioengineered protein-based nanocage for drug delivery.
    Lee EJ; Lee NK; Kim IS
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):157-171. PubMed ID: 26994591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triggered Reversible Disassembly of an Engineered Protein Nanocage*.
    Jones JA; Cristie-David AS; Andreas MP; Giessen TW
    Angew Chem Int Ed Engl; 2021 Nov; 60(47):25034-25041. PubMed ID: 34532937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redesign of protein nanocages: the way from 0D, 1D, 2D to 3D assembly.
    Lv C; Zhang X; Liu Y; Zhang T; Chen H; Zang J; Zheng B; Zhao G
    Chem Soc Rev; 2021 Mar; 50(6):3957-3989. PubMed ID: 33587075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioengineered vaults: self-assembling protein shell-lipophilic core nanoparticles for drug delivery.
    Buehler DC; Marsden MD; Shen S; Toso DB; Wu X; Loo JA; Zhou ZH; Kickhoefer VA; Wender PA; Zack JA; Rome LH
    ACS Nano; 2014 Aug; 8(8):7723-32. PubMed ID: 25061969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle mediated non-covalent drug delivery.
    Doane T; Burda C
    Adv Drug Deliv Rev; 2013 May; 65(5):607-21. PubMed ID: 22664231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biomedical and bioengineering potential of protein nanocompartments.
    Demchuk AM; Patel TR
    Biotechnol Adv; 2020; 41():107547. PubMed ID: 32294494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioengineering Strategies for Protein-Based Nanoparticles.
    Diaz D; Care A; Sunna A
    Genes (Basel); 2018 Jul; 9(7):. PubMed ID: 30041491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutics and carriers: the dual role of proteins in nanoparticles for ocular delivery.
    Pescina S; Sonvico F; Santi P; Nicoli S
    Curr Top Med Chem; 2015; 15(4):369-85. PubMed ID: 25579343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.
    Witting M; Obst K; Friess W; Hedtrich S
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1355-69. PubMed ID: 25687276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic and bioinspired strategies for oral drug delivery.
    Hu X; Yang G; Chen S; Luo S; Zhang J
    Biomater Sci; 2020 Feb; 8(4):1020-1044. PubMed ID: 31621709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium nanoparticles: potential in cancer gene and drug delivery.
    Maiyo F; Singh M
    Nanomedicine (Lond); 2017 May; 12(9):1075-1089. PubMed ID: 28440710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma targeting peptide modified apoferritin nanocage.
    Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C
    Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered Hsp Protein Nanocages for siRNA Delivery.
    Guan X; Chang Y; Sun J; Song J; Xie Y
    Macromol Biosci; 2018 May; 18(5):e1800013. PubMed ID: 29665276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein nanoparticles for therapeutic protein delivery.
    Herrera Estrada LP; Champion JA
    Biomater Sci; 2015 Jun; 3(6):787-99. PubMed ID: 26221839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biogenic and Biomimetic Carriers as Versatile Transporters To Treat Infections.
    Goes A; Fuhrmann G
    ACS Infect Dis; 2018 Jun; 4(6):881-892. PubMed ID: 29553240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery of proteins by biodegradable nanoparticles.
    Bakhru SH; Furtado S; Morello AP; Mathiowitz E
    Adv Drug Deliv Rev; 2013 Jun; 65(6):811-21. PubMed ID: 23608641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of PLGA-mannosamine nanoparticles as oral protein carriers.
    Alonso-Sande M; des Rieux A; Fievez V; Sarmento B; Delgado A; Evora C; Remuñán-López C; Préat V; Alonso MJ
    Biomacromolecules; 2013 Nov; 14(11):4046-52. PubMed ID: 24131254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles in drug delivery: past, present and future.
    Couvreur P
    Adv Drug Deliv Rev; 2013 Jan; 65(1):21-3. PubMed ID: 22580334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of protein-based nanocages for imaging and drug delivery.
    Corsi F; Mazzucchelli S
    Ther Deliv; 2016; 7(3):149-51. PubMed ID: 26893245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.